Evidence of polyclonal hematopoiesis in a large proportion of patients with low-risk myelodysplastic syndrome.

被引：0
|
作者：
Malcovati, L
Della Porta, MG
Galli, A
Boggi, S
Malabarba, L
Pietra, D
Passamonti, F
Bergamaschi, G
Lazzarino, M
Cazzola, M
机构：
[1] Univ Pavia, Div Hematol, Sch Med, I-27100 Pavia, Italy
[2] Policlin San Matteo, IRCCS, I-27100 Pavia, Italy
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2364
引用
收藏
页码：649A / 650A
页数：2
相关论文
共 50 条
  • [1] The role of rHuEpo in low-risk myelodysplastic syndrome patients
    Rigolin, GM
    Castoldi, G
    LEUKEMIA & LYMPHOMA, 2005, 46 (06) : 823 - 831
  • [2] Experience with the use of azacitidine in patients with low-risk myelodysplastic syndrome
    Duarte, F.
    Santos, T.
    Barbosa, M.
    Santos, T.
    Goncalves, R.
    LEUKEMIA RESEARCH, 2013, 37 : S166 - S166
  • [3] Clinical outcome in three patients with myelodysplastic syndrome showing polyclonal hematopoiesis
    Karasawa, M
    Tsukamoto, N
    Sakai, H
    Okamoto, K
    Maehara, T
    Naruse, T
    Morita, K
    Sato, S
    ACTA HAEMATOLOGICA, 1999, 101 (01) : 46 - 49
  • [4] Leukaemia cutis in a patient with low-risk myelodysplastic syndrome
    Lin, Jinran
    Zhang, Qiao'an
    Chen, Minghua
    JOURNAL OF DERMATOLOGY, 2010, 37 : 42 - 42
  • [5] Past, present and future in low-risk myelodysplastic syndrome
    Toprak, Selami Kocak
    FRONTIERS IN MEDICINE, 2022, 9
  • [6] Increased Apoptotic Activity in Low-Risk Myelodysplastic Syndrome
    Park, Songyi
    Shin, Dong-Yeop
    Park, Junseo Steve
    Park, Hee Sue
    Moon, Soo Young
    Yoon, Sung-Soo
    Lee, Dong-Soon
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [7] Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome
    Sternberg, A
    Killick, S
    Littlewood, T
    Hatton, C
    Peniket, A
    Seidl, T
    Soneji, S
    Leach, J
    Bowen, D
    Chapman, C
    Standen, G
    Massey, E
    Robinson, L
    Vadher, B
    Kaczmarski, R
    Janmohammed, R
    Clipsham, K
    Carr, A
    Vyas, P
    BLOOD, 2005, 106 (09) : 2982 - 2991
  • [8] Should Patients with Low-Risk Myelodysplastic Syndrome be Treated Earlier in the Course of Their Disease?
    Eric J. Feldman
    Current Hematologic Malignancy Reports, 2011, 6 : 1 - 2
  • [9] Should Patients with Low-Risk Myelodysplastic Syndrome be Treated Earlier in the Course of Their Disease?
    Feldman, Eric J.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (01) : 1 - 2
  • [10] INFERIOR OUTCOME IN LOW-RISK MYELODYSPLASTIC SYNDROME PATIENTS EXHIBITING IRON OVERLOAD
    Sumoza, M.
    Yellapragada, S.
    Roque, W.
    Mims, M.
    Rivero, G.
    LEUKEMIA RESEARCH, 2015, 39 : S138 - S138
12345